tiprankstipranks
Genmab A/S (DE:GE9)
XETRA:GE9
Germany Market

Genmab A/S (GE9) Financial Statements

15 Followers

Genmab A/S Financial Overview

Genmab A/S's market cap is currently €17.30B. The company's EPS TTM is €105.36; its P/E ratio is 26.28; Genmab A/S is scheduled to report earnings on August 6, 2026, and the estimated EPS forecast is €3.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 3.86Bkr 21.53Bkr 16.47Bkr 14.51Bkr 8.48B
Gross Profit$ 3.54Bkr 20.54Bkr 16.25Bkr 14.51Bkr 8.48B
Operating Income$ 1.30Bkr 7.00Bkr 5.32Bkr 6.30Bkr 2.95B
EBITDA$ 1.37Bkr 9.70Bkr 5.99Bkr 7.33Bkr 3.27B
Net Income$ 999.19Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Balance Sheet
Cash & Short-Term Investments$ 1.71Bkr 21.10Bkr 28.14Bkr 22.32Bkr 19.34B
Total Assets$ 12.84Bkr 45.81Bkr 35.29Bkr 30.12Bkr 24.63B
Total Debt$ 5.55Bkr 1.03Bkr 770.00Mkr 597.00Mkr 425.00M
Net Debt$ 3.84Bkr -8.83Bkr -14.10Bkr -9.30Bkr -8.53B
Total Liabilities$ 7.01Bkr 9.11Bkr 3.68Bkr 2.84Bkr 2.43B
Stockholders' Equity$ 5.83Bkr 36.70Bkr 31.61Bkr 27.28Bkr 22.20B
Cash Flow
Free Cash Flow$ 1.19Bkr 7.58Bkr 7.00Bkr 3.60Bkr 1.98B
Operating Cash Flow$ 1.23Bkr 7.77Bkr 7.38Bkr 3.91Bkr 2.23B
Investing Cash Flow$ -5.86Bkr -9.91Bkr -1.28Bkr -2.76Bkr -961.00M
Financing Cash Flow$ 4.97Bkr -3.92Bkr -606.00Mkr -789.00Mkr -420.00M

Genmab A/S Earnings and Revenue History

Genmab A/S Debt to Assets

Genmab A/S Cash Flow

Genmab A/S Forecast EPS vs Actual EPS